WILMINGTON, Del., Dec. 27, 2017 /PRNewswire/ — NeuroRx, a clinical stage biopharma company developing the first drug regimen to treat severe bipolar depression in patients with Acute Suicidal Ideation and Behavior (ASIB), announced that it has signed a Cooperative Research and…
